Severe Polypharmacy Increases Risk of Hospitalization Among Older Adults with IBD.

Darren Drittel William Schreiber-StainthorpOlivia DelauSakteesh V Gurunathan Joshua Chodosh Dorry L Segev Mara A McAdams-DeMarco Seymour KatzJohn DodsonAasma ShaukatAdam S Faye

Published in: The American journal of gastroenterology (2024)

Severe polypharmacy was initially present in more than 25% of older adults with IBD and increased to 34% within 4 years of index visit. Severe polypharmacy, as well as PIM utilization among those with polypharmacy, were also associated with an increased risk of hospitalization at one-year, highlighting the need for deprescribing efforts in this population.

Keyphrases

early onset
adverse drug
physical activity
drug induced
middle aged
quality improvement